Featured Research

from universities, journals, and other organizations

Risks Outweigh Benefits Of Shark Cartilage As Anti-cancer Treatment

Date:
May 23, 2005
Source:
John Wiley & Sons, Inc.
Summary:
As a treatment for advanced cancer, shark cartilage fails to benefit patients and its adverse effects lead to poor compliance. A clinical trial finds there was no difference in overall survival or quality of life between patients who received shark cartilage and those who received a placebo.

As a treatment for advanced cancer, shark cartilage fails to benefit patients and its adverse effects lead to poor compliance. A clinical trial published in the July 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society, finds there was no difference in overall survival or quality of life between patients who received shark cartilage and those who received a placebo.

Some experiments have shown that some forms of shark cartilage possess a modest ability to slow the growth of new blood vessels in laboratory cell cultures and in animals, but the effects on humans are not known. Interest in shark cartilage grew after a television news magazine aired a segment in 1993 that showed patients with advanced cancer in Cuba who had gone into remission after being treated with shark cartilage. The results of the study were never published in a peer-reviewed medical journal, and the National Cancer Institute (NCI) later concluded the results of the Cuban study were "incomplete and unimpressive."

Mayo Clinic Oncologist Charles L. Loprinzi, M.D., and his colleagues in the North Central Cancer Treatment Group (NCCTG) designed and conducted a randomized, placebo-controlled, double-blind clinical trial to investigate the efficacy associated with shark cartilage as a treatment for breast and colorectal cancer.

Toxicity related to shark cartilage resulted in significant trial drop out after one month. There was no suggestion that shark cartilage caused any improvement in overall survival nor any significant improvement in quality of life. In fact, some quality of life measurements tended to worsen among patients treated with shark cartilage.

The authors conclude, "shark cartilage did not demonstrate any efficacy in patients with advanced breast or colorectal cancers."

###

Article: "Evaluation of Shark Cartilage in Patients with Advanced Cancer: A North Central Cancer Treatment Group Trial," Charles L. Loprinzi, Ralph Levitt, Debra Barton, Jeff Sloan, Pam Atherton, Denise Smith, Shaker Dakhil, Dennis Moore, Jr., James E. Krook, Kendrith M. Rowland, Jr., Miroslaw Mazurczak, Alan Berg, George Kim, CANCER; Published Online: May 23, 2005 (DOI: 10.1002/cncr.21107); Print Issue Date: July 1, 2005.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "Risks Outweigh Benefits Of Shark Cartilage As Anti-cancer Treatment." ScienceDaily. ScienceDaily, 23 May 2005. <www.sciencedaily.com/releases/2005/05/050523093339.htm>.
John Wiley & Sons, Inc.. (2005, May 23). Risks Outweigh Benefits Of Shark Cartilage As Anti-cancer Treatment. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/05/050523093339.htm
John Wiley & Sons, Inc.. "Risks Outweigh Benefits Of Shark Cartilage As Anti-cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/2005/05/050523093339.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins